54 results
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
collaboration arrangements; market share; net income; net profit; net sales; new product or business development; new product invention or innovation; number
424B5
egikbt v8kokt
10 Nov 21
Prospectus supplement for primary offering
7:23am
424B3
g8mb77zsk
15 Jul 21
Prospectus supplement
4:45pm
S-4
pwe6fjwzi2dq1
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
10-K
EX-21.1
86t6xpkyr94rqxhsc
29 Jun 20
Annual report
4:02pm
10-K
wl47hhp9j 2ct
29 Jun 20
Annual report
4:02pm
6-K
EX-99.2
4axil2m hd
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
iq7xkx
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
ohnjfodn1 l2
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
hhram 3nrwuudz
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am